- Report
- October 2023
- 82 Pages
United States
From €3127EUR$3,500USD£2,703GBP
- Drug Pipelines
- April 2025
- 60 Pages
Global
From €1787EUR$2,000USD£1,544GBP
- Clinical Trials
- April 2025
- 80 Pages
Global
From €1787EUR$2,000USD£1,544GBP
- Clinical Trials
- April 2025
- 80 Pages
Global
From €1787EUR$2,000USD£1,544GBP
- Drug Pipelines
- April 2025
- 80 Pages
Global
From €1787EUR$2,000USD£1,544GBP
- Clinical Trials
- April 2025
- 280 Pages
Global
From €2680EUR$3,000USD£2,317GBP
- Clinical Trials
- April 2025
- 60 Pages
Global
From €1340EUR$1,500USD£1,158GBP
- Drug Pipelines
- April 2025
- 60 Pages
Global
From €1340EUR$1,500USD£1,158GBP
- Clinical Trials
- April 2025
- 60 Pages
Global
From €1340EUR$1,500USD£1,158GBP
- Clinical Trials
- April 2025
- 60 Pages
Global
From €1340EUR$1,500USD£1,158GBP
- Clinical Trials
- April 2025
- 60 Pages
Global
From €1340EUR$1,500USD£1,158GBP
- Clinical Trials
- April 2025
- 60 Pages
Global
From €1340EUR$1,500USD£1,158GBP
- Clinical Trials
- April 2025
- 40 Pages
Global
From €1117EUR$1,250USD£965GBP
- Clinical Trials
- April 2025
- 60 Pages
Global
From €1117EUR$1,250USD£965GBP
- Clinical Trials
- April 2025
- 60 Pages
Global
From €1117EUR$1,250USD£965GBP
- Clinical Trials
- April 2025
- 60 Pages
Global
From €1117EUR$1,250USD£965GBP
- Clinical Trials
- April 2025
- 60 Pages
Global
From €1117EUR$1,250USD£965GBP
- Clinical Trials
- April 2025
- 60 Pages
Global
From €1117EUR$1,250USD£965GBP
- Report
- September 2024
- 132 Pages
Global
From €7102EUR$7,950USD£6,139GBP
- Report
- August 2024
- 233 Pages
Global
From €7102EUR$7,950USD£6,139GBP

Serotonin is a neurotransmitter found in the central nervous system (CNS) that plays a role in regulating mood, appetite, sleep, and other bodily functions. It is a key target for drugs used to treat depression, anxiety, and other mental health disorders. Serotonin-based drugs are typically selective serotonin reuptake inhibitors (SSRIs) or serotonin-norepinephrine reuptake inhibitors (SNRIs). These drugs work by blocking the reuptake of serotonin, allowing it to remain active in the brain for longer periods of time.
The serotonin market is a subset of the larger CNS drug market, which is estimated to be worth billions of dollars. It is a highly competitive market, with many large pharmaceutical companies vying for market share. Companies in the serotonin market include Eli Lilly, Pfizer, GlaxoSmithKline, AstraZeneca, and Bristol-Myers Squibb. Show Less Read more